{
    "address1": "333 Lakeside Drive",
    "city": "Foster City",
    "state": "CA",
    "zip": "94404",
    "country": "United States",
    "phone": "650 574 3000",
    "fax": "650 522 5853",
    "website": "https://www.gilead.com",
    "industry": "Drug Manufacturers\u2014General",
    "sector": "Healthcare",
    "longBusinessSummary": "Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Merck & Co, Inc. and Tentarix Biotherapeutics Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.",
    "fullTimeEmployees": 17000,
    "companyOfficers": [
        {
            "maxAge": 1,
            "name": "Mr. Daniel P.  O'Day",
            "age": 58,
            "title": "Chairman & CEO",
            "yearBorn": 1964,
            "fiscalYear": 2022,
            "totalPay": 7267338,
            "exercisedValue": 0,
            "unexercisedValue": 9635551
        },
        {
            "maxAge": 1,
            "name": "Mr. Andrew D. Dickinson",
            "age": 52,
            "title": "Exec. VP & CFO",
            "yearBorn": 1970,
            "fiscalYear": 2022,
            "totalPay": 2935112,
            "exercisedValue": 0,
            "unexercisedValue": 5436829
        },
        {
            "maxAge": 1,
            "name": "Ms. Deborah H. Telman",
            "age": 57,
            "title": "Exec. VP of Corp. Affairs, Gen. Counsel & Corp. Sec.",
            "yearBorn": 1965,
            "fiscalYear": 2022,
            "totalPay": 2323080,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Ms. Johanna  Mercier",
            "age": 52,
            "title": "Chief Commercial Officer",
            "yearBorn": 1970,
            "fiscalYear": 2022,
            "totalPay": 3322200,
            "exercisedValue": 0,
            "unexercisedValue": 3864125
        },
        {
            "maxAge": 1,
            "name": "Dr. Merdad V. Parsey M.D., Ph.D.",
            "age": 59,
            "title": "Chief Medical Officer",
            "yearBorn": 1963,
            "fiscalYear": 2022,
            "totalPay": 3074714,
            "exercisedValue": 0,
            "unexercisedValue": 3047349
        },
        {
            "maxAge": 1,
            "name": "Ms. Sandra  Patterson",
            "age": 55,
            "title": "Sr. VP, Corp. Controller & Principal Accounting Officer",
            "yearBorn": 1967,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Ms. Jacquie  Ross C.F.A.",
            "title": "VP of Investor Relations",
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Ms. Jyoti K. Mehra",
            "age": 46,
            "title": "Exec. VP of HR",
            "yearBorn": 1976,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Dr. Michael  Quigley Ph.D.",
            "title": "Sr. VP of Research Biology",
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Dr. Linda Slanec Higgins Ph.D.",
            "age": 60,
            "title": "Sr. VP of Research, Innovation & Portfolio",
            "yearBorn": 1962,
            "exercisedValue": 0,
            "unexercisedValue": 0
        }
    ],
    "auditRisk": 3,
    "boardRisk": 4,
    "compensationRisk": 3,
    "shareHolderRightsRisk": 1,
    "overallRisk": 1,
    "governanceEpochDate": 1693526400,
    "compensationAsOfEpochDate": 1672444800,
    "maxAge": 86400,
    "priceHint": 2,
    "previousClose": 73.94,
    "open": 76.12,
    "dayLow": 75.06,
    "dayHigh": 76.595,
    "regularMarketPreviousClose": 73.94,
    "regularMarketOpen": 76.12,
    "regularMarketDayLow": 75.06,
    "regularMarketDayHigh": 76.595,
    "dividendRate": 3.0,
    "dividendYield": 0.040599998,
    "exDividendDate": 1694649600,
    "payoutRatio": 0.68050003,
    "fiveYearAvgDividendYield": 3.91,
    "beta": 0.386583,
    "trailingPE": 17.471264,
    "forwardPE": 10.497238,
    "volume": 6695505,
    "regularMarketVolume": 6695505,
    "averageVolume": 5651619,
    "averageVolume10days": 5128470,
    "averageDailyVolume10Day": 5128470,
    "bid": 0.0,
    "ask": 0.0,
    "bidSize": 900,
    "askSize": 800,
    "marketCap": 94696759296,
    "fiftyTwoWeekLow": 61.45,
    "fiftyTwoWeekHigh": 89.74,
    "priceToSalesTrailing12Months": 3.458358,
    "fiftyDayAverage": 77.2176,
    "twoHundredDayAverage": 81.06045,
    "trailingAnnualDividendRate": 2.96,
    "trailingAnnualDividendYield": 0.040032458,
    "currency": "USD",
    "enterpriseValue": 112781090816,
    "profitMargins": 0.20028,
    "floatShares": 1244656197,
    "sharesOutstanding": 1246009984,
    "sharesShort": 19632045,
    "sharesShortPriorMonth": 17568860,
    "sharesShortPreviousMonthDate": 1689292800,
    "dateShortInterest": 1692057600,
    "sharesPercentSharesOut": 0.015800001,
    "heldPercentInsiders": 0.001,
    "heldPercentInstitutions": 0.86845,
    "shortRatio": 3.31,
    "shortPercentOfFloat": 0.0176,
    "bookValue": 16.967,
    "priceToBook": 4.4792833,
    "lastFiscalYearEnd": 1672444800,
    "nextFiscalYearEnd": 1703980800,
    "mostRecentQuarter": 1688083200,
    "earningsQuarterlyGrowth": -0.087,
    "netIncomeToCommon": 5484000256,
    "trailingEps": 4.35,
    "forwardEps": 7.24,
    "pegRatio": 3.19,
    "lastSplitFactor": "2:1",
    "lastSplitDate": 1359331200,
    "enterpriseToRevenue": 4.119,
    "enterpriseToEbitda": 9.272,
    "exchange": "NMS",
    "quoteType": "EQUITY",
    "symbol": "GILD",
    "underlyingSymbol": "GILD",
    "shortName": "Gilead Sciences, Inc.",
    "longName": "Gilead Sciences, Inc.",
    "firstTradeDateEpochUtc": 696090600,
    "timeZoneFullName": "America/New_York",
    "timeZoneShortName": "EDT",
    "gmtOffSetMilliseconds": -14400000,
    "currentPrice": 76.0,
    "targetHighPrice": 116.0,
    "targetLowPrice": 71.0,
    "targetMeanPrice": 90.56,
    "targetMedianPrice": 90.0,
    "recommendationMean": 2.5,
    "recommendationKey": "buy",
    "numberOfAnalystOpinions": 25,
    "totalCash": 7097999872,
    "totalCashPerShare": 5.697,
    "ebitda": 12163999744,
    "totalDebt": 25245999104,
    "quickRatio": 0.811,
    "currentRatio": 1.023,
    "totalRevenue": 27381999616,
    "debtToEquity": 119.683,
    "revenuePerShare": 21.871,
    "returnOnAssets": 0.09774,
    "returnOnEquity": 0.26348,
    "grossProfits": 21624000000,
    "freeCashflow": 9621499904,
    "operatingCashflow": 9511999488,
    "earningsGrowth": -0.088,
    "revenueGrowth": 0.054,
    "grossMargins": 0.79424006,
    "ebitdaMargins": 0.44423,
    "operatingMargins": 0.35753,
    "financialCurrency": "USD",
    "trailingPegRatio": 0.5117,
    "parent_etfs": [
        "GNOM"
    ]
}